Monensin induced suicidal erythrocyte death.
Study Design
- Tipo de estudio
- Other
- Población
- None
- Intervención
- Monensin induced suicidal erythrocyte death. None
- Comparador
- None
- Resultado primario
- None
- Dirección del efecto
- Positive
- Riesgo de sesgo
- Unclear
Abstract
Eryptosis, the suicidal erythrocyte death, is characterized by cell membrane scrambling and cell shrinkage. Eryptosis may be triggered by excessive hyperosmotic or isosmotic cell shrinkage leading to increase of cytosolic Ca(2+) concentration. Eryptosis is further stimulated by the K(+) ionophore valinomycin, which leads to exit of KCl and osmotically obliged water, or by energy (glucose) depletion, which compromises the function of the Na(+)/K(+) ATPase thus increasing cytosolic Na(+) concentration. The present study explored whether the Na(+) ionophore monensin affects erythrocyte cell volume and eryptosis. The cell membrane scrambling was estimated from binding of annexin V to phosphatidylserine at the erythrocyte surface, cell volume from forward scatter in FACS analysis, cytosolic Ca(2+) concentration from Fluo3 fluorescence and the cytosolic ATP concentration from a luciferase-based assay. Within 24 hours, exposure to monensin (0.1-10 microg/ml) significantly increased forward scatter, cytosolic Ca(2+) concentration and annexin V-binding. Glucose depletion was followed by decreased forward scatter and increased cytosolic Ca(2+) concentration and annexin V-binding. The effect on forward scatter was partially reversed, the effect on cytosolic Ca(2+) concentration and annexin V binding augmented by additional treatment with monensin. In conclusion, monensin dissociates the alterations of cell membrane and cell volume in suicidal erythrocyte death.
TL;DR
Investigation of whether the Na+ ionophore monensin affects erythrocyte cell volume and eryptosis found it dissociates the alterations of cell membrane and cell volume in suicidal ery Throatcyte death.
Used In Evidence Reviews
Similar Papers
Cellular and molecular life sciences : CMLS · 2005
Surface exposure of phosphatidylserine in pathological cells.
Molecular medicine (Cambridge, Mass.) · 2011
Severe alterations in lipid composition of frontal cortex lipid rafts from Parkinson's disease and incidental Parkinson's disease.
Cell · 1983
Inhibition of VSV binding and infectivity by phosphatidylserine: is phosphatidylserine a VSV-binding site?
Journal of Alzheimer's disease : JAD · 2012
Plasma and brain fatty acid profiles in mild cognitive impairment and Alzheimer's disease.
Current opinion in hematology · 2000
Oxidation and erythrocyte senescence.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2006